Condition
Esophageal Varices Bleeding
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06961474Active Not RecruitingPrimary
Effectiveness of Treatments for Cirrhosis With Varicose Veins
NCT05302661Not ApplicableUnknown
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis
NCT03683121UnknownPrimary
The Compliance and Prognosis of NSBB Secondary Prevention of Cirrhosis With Gastroesophageal Varices Bleeding
Showing all 3 trials